Neulasta  - Drug Details
📊 Estimates Neulasta  Dialyzability By Different_Modalities

Neulasta 

Complete Drug Information

Drug Name
Neulasta 
Trade Names
Neulasta
Pregnancy Category
AU: B3
Routes of Administration
Subcutaneous
Elimination
15–80 hrs
Formula
C845H1343N223O243S9
Molar Mass
18802.9
Drug Class
Hematopoietic agents, colony-stimulating factors, immunostimulants
Volume of Distribution
C845H1343N223O243S9

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.